In order to test the potential impact of APE1 L104R, D148E, R237C and D283G mutants on protein intracellular localization, the corresponding transiently-transfected HeLa cells were assayed by immunofluorescence analysis. All the variants displayed a subcellular distribution comparable to that of APE1 WT , with a predominant nucleoplasmic localization associated with an apparent nucleolar accumulation (Supplementary Figure S1 ).
SUPPLEMENTARY INFORMATION ON EXPERIMENTAL PROCEDURES Inducible APE1 knock-down and generation of APE1 knock-in cell lines
All these procedures have been described previously [1, 2] . For the generation of HeLa reconstituted APE1 variants, APE1 variants expression vector was generated by cloning an EcoRI-BamHI fragment from pFLAG-CMV-5.1/ APE1 (Sigma-Aldrich, Milan, Italy) into p3XFLAG-CMV-14 vector (Sigma-Aldrich, Milan, Italy). To avoid the degradation of the ectopic APE1 mRNA, two nucleotides of the APE1-cDNA coding sequence were mutated by using the Site-Directed Mutagenesis Kit (Stratagene, Santa Clara, CA), leaving unaffected the APE1 amino acid sequence: siRNA: 5′-CCTGCCACACTCAAGATCTGC-3′; APE1: 5′-CCTGCAACGCTCAAGATCTGC-3′.
The SiteDirected Mutagenesis Kit was used to generate the APE1 genetic variants. All the mutants were confirmed by DNA sequencing (MWG, Ebersberg, Germany). Then, the APE1 siRNA clone was transfected with p3XFLAG-CMV/APE1
WT and genetic variants, previously digested with ScaI (Thermo Scientific, Milan, Italy). Forty-eight h after transfection, the cells were subjected to selection with geneticin (Invitrogen, Carlsbad, CA) for 14 days, and selected for the acquired resistance. Individual cell clones were isolated by using cell cloning cylinders (SigmaAldrich, Milan, Italy), transferred and grown for expansion to 10 7 cells in the presence of selective antibiotics. As control, the siRNA control clone was transfected with the p3XFLAG-CMV-14 empty vector. After 10 days of doxycycline treatment at the final concentration of 1 μg/ml, total extracts were analyzed for APE1 expression by immunoblotting, thus revealing the silencing of the endogenous APE1 and the expression of the ectopic flagged wild-type and variants of the protein.
Immunofluorescence and confocal microscopy
For immunofluorescence analyses, cells were plated onto glass coverslips, fixed with 4% w/v paraformaldehyde for 20 min at room temperature and permeabilized with PBS containing 0.1% v/v Triton X-100. Cells were saturated with 10% v/v fetal bovine serum in TBS/0.1% v/v Tween-20 for 1 h, at room temperature, incubated with the α-FLAG antibody (1:200) for 2 h at 37°C, and then washed three times with TBS containing 0.1% Triton X-100, each for 5 min. Alexa Fluor 488-conjugated secondary antibody (Jackson ImmunoResearch, West Grove, PA) was used for detection. DNA was labelled with TO-PRO3 ® (Sigma-Aldrich, Milan, Italy). Confocal fluorescent images were obtained using a Leica TCS SP laser-scanning confocal microscope (Leica Microsystems, Wetzlar, Germany) equipped with a 488 nm-argon laser, a 543 nm-HeNe laser, and a63 × oil immersion objective (HCX PL APO CS 63 ×/1.32-0.60; Leica). Data were acquired at room temperature (23°C) using the integrated Leica Confocal Software package; multicolor images were captured through sequential scanning.
Antibodies for Western blotting and immunofluorescence
Monoclonal α-APE1 was from Novus (NB 100-116); polyclonal Gadd45 was from Santa Cruz (sc797); monoclonal p21 was from Cell Signaling (#2947); monoclonal α-PARP1cv was from Novus (NB100-56599); monoclonal α-Poly(ADP-ribose) (PAR) was from Adipogen (10H); monoclonal γH2Ax was from Millipore (05-636); monoclonal α-XRCC1 was from Thermo Scientific (MS-434-P0); polyclonal α-Polβ was from Abcam (ab26343); monoclonal α-FLAG was from Sigma (F1804); polyclonal α-actin and monoclonal α-tubulin were from Sigma (A2066 and T-9026, respectively); monoclonal α-p62 was from BD Biosciences (610832) and polyclonal α-LC3 was from Cell Signaling (2775). Polyclonal Ki67 was a kind gift from Dr. Antonio Beltrami.
